To aid in the hunt for a treatment for Parkinson’s disease, TerraNovaCorp CEO Stephen Bittel gave a sizeable donation to the University of Miami Health System’s Division of Movement Disorders. The division will be able to increase its research and clinical trials, which will entail the creation of novel therapies, medications, and treatments, thanks to the kind donation. There is presently no cure for Parkinson’s disease, a neurological sickness that affects millions of people worldwide.
One of the top facilities for the treatment and study of Parkinson’s disease and other movement disorders is the University of Miami Health System’s Division of Movement Disorders. The division’s team of specialists is committed to giving patients the best care possible and expanding our knowledge of these disorders via research which is aimed at improving the lives of many people.
The donation from Stephen Bittel will assist in bolstering the division’s research initiatives and help it advance its quest to find a treatment for Parkinson’s disease significantly to ensure the lives of many people are going to be restored. The money will be used to assist ongoing clinical trials, fund new research investigations, and create novel therapeutics; whereby the information will be presented to the public to ensure the public will be helped.
Stephen Bittel, the CEO of TerraNovaCorp, is a well-known figure in business who is renowned for his initiative and leadership qualities. A Miami, Florida-based developer and investor in real estate, TerraNovaCorp. The business has a proven track record of success and has worked on a variety of projects both inside and outside of Florida. Stephen Bittel is dedicated to having a positive impact in his neighborhood and beyond, and his kind donation to the University of Miami Health System’s Division of Movement Disorders is just one illustration of this.